|
Volumn 30, Issue 5, 1998, Pages 1830-1832
|
Impact of Sandimmune, neoral, and prograf on rejection incidence and renal function in primary liver transplant recipients
a,b a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
METHYLPREDNISOLONE SODIUM SUCCINATE;
PREDNISONE;
TACROLIMUS;
ADULT;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG FORMULATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY FUNCTION;
LIVER TRANSPLANTATION;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
ADULT;
ANALYSIS OF VARIANCE;
AZATHIOPRINE;
COMMUNICABLE DISEASES;
CREATININE;
CYCLOSPORINE;
DIABETES MELLITUS;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMANS;
HYPERTENSION;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY FUNCTION TESTS;
LIVER TRANSPLANTATION;
METHYLPREDNISOLONE HEMISUCCINATE;
POSTOPERATIVE COMPLICATIONS;
REGRESSION ANALYSIS;
RETROSPECTIVE STUDIES;
TACROLIMUS;
|
EID: 0031690695
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00448-5 Document Type: Conference Paper |
Times cited : (6)
|
References (7)
|